Connection

Qiuwei Pan to Humans

Back to Details
This is a "connection" page, showing publications Qiuwei Pan has written about Humans.
Qiuwei Pan
Connection Strength
0.254
Humans
  1. Systematically Mapping Clinical Features of Infections With Classical Endemic Human Coronaviruses. Clin Infect Dis. 2021 08 02; 73(3):554-555.
    View in: PubMed
    Score: 0.008
  2. Systematically comparing COVID-19 with the 2009 influenza pandemic for hospitalized patients. Int J Infect Dis. 2021 Jan; 102:375-380.
    View in: PubMed
    Score: 0.007
  3. Estimating Global Epidemiology of Low-Pathogenic Human Coronaviruses in Relation to the COVID-19 Context. J Infect Dis. 2020 07 23; 222(4):695-696.
    View in: PubMed
    Score: 0.007
  4. Overwhelming COVID-19 Clinical Trials: Call for Prospective Meta-Analyses. Trends Pharmacol Sci. 2020 08; 41(8):501-503.
    View in: PubMed
    Score: 0.007
  5. Potential association between COVID-19 mortality and health-care resource availability. Lancet Glob Health. 2020 04; 8(4):e480.
    View in: PubMed
    Score: 0.007
  6. Mitochondria in the biology, pathogenesis, and treatment of hepatitis virus infections. Rev Med Virol. 2019 09; 29(5):e2075.
    View in: PubMed
    Score: 0.007
  7. Efficacy of Different Endoscopic Stents in the Management of Postoperative Biliary Strictures: A Systematic Review and Meta-analysis. J Clin Gastroenterol. 2019 07; 53(6):418-426.
    View in: PubMed
    Score: 0.007
  8. Suppression of Hepatocellular Carcinoma by Mycophenolic Acid in Experimental Models and in Patients. Transplantation. 2019 05; 103(5):929-937.
    View in: PubMed
    Score: 0.007
  9. Outcome of a screening program for the prevention of neonatal early-onset group B Streptococcus infection: a population-based cohort study in Inner Mongolia, China. J Med Microbiol. 2019 May; 68(5):803-811.
    View in: PubMed
    Score: 0.007
  10. Errors in translational decoding: tRNA wobbling or misincorporation? PLoS Genet. 2019 03; 15(3):e1008017.
    View in: PubMed
    Score: 0.007
  11. No Clear Evidence for an Effect of Sofosbuvir Against Hepatitis E Virus in Organ Transplant Patients. Hepatology. 2019 04; 69(4):1846-1847.
    View in: PubMed
    Score: 0.007
  12. Modeling liver cancer and therapy responsiveness using organoids derived from primary mouse liver tumors. Carcinogenesis. 2019 03 12; 40(1):145-154.
    View in: PubMed
    Score: 0.007
  13. Direct-acting antiviral agents for liver transplant recipients with recurrent genotype 1 hepatitis C virus infection: Systematic review and meta-analysis. Transpl Infect Dis. 2019 Apr; 21(2):e13047.
    View in: PubMed
    Score: 0.006
  14. The Burden of Human Papillomavirus and Chlamydia trachomatis Coinfection in Women: A Large Cohort Study in Inner Mongolia, China. J Infect Dis. 2019 01 07; 219(2):206-214.
    View in: PubMed
    Score: 0.006
  15. Advancing the understanding of NAFLD to hepatocellular carcinoma development: From experimental models to humans. Biochim Biophys Acta Rev Cancer. 2019 01; 1871(1):117-125.
    View in: PubMed
    Score: 0.006
  16. Nitazoxanide Inhibits Human Norovirus Replication and Synergizes with Ribavirin by Activation of Cellular Antiviral Response. Antimicrob Agents Chemother. 2018 11; 62(11).
    View in: PubMed
    Score: 0.006
  17. Effective Treatment of Chronic Proliferative Cholangitis by Local Gentamicin Infusion in Rabbits. Biomed Res Int. 2018; 2018:6751952.
    View in: PubMed
    Score: 0.006
  18. 6-Thioguanine inhibits rotavirus replication through suppression of Rac1 GDP/GTP cycling. Antiviral Res. 2018 08; 156:92-101.
    View in: PubMed
    Score: 0.006
  19. Basal interferon signaling and therapeutic use of interferons in controlling rotavirus infection in human intestinal cells and organoids. Sci Rep. 2018 05 29; 8(1):8341.
    View in: PubMed
    Score: 0.006
  20. IRF-1, RIG-I and MDA5 display potent antiviral activities against norovirus coordinately induced by different types of interferons. Antiviral Res. 2018 07; 155:48-59.
    View in: PubMed
    Score: 0.006
  21. The RNA genome of hepatitis E virus robustly triggers an antiviral interferon response. Hepatology. 2018 06; 67(6):2096-2112.
    View in: PubMed
    Score: 0.006
  22. Significance of continuous rotavirus and norovirus surveillance in Indonesia. World J Pediatr. 2018 02; 14(1):4-12.
    View in: PubMed
    Score: 0.006
  23. Immunity against hepatitis E virus infection: Implications for therapy and vaccine development. Rev Med Virol. 2018 Mar; 28(2).
    View in: PubMed
    Score: 0.006
  24. Inhibition of Calcineurin or IMP Dehydrogenase Exerts Moderate to Potent Antiviral Activity against Norovirus Replication. Antimicrob Agents Chemother. 2017 11; 61(11).
    View in: PubMed
    Score: 0.006
  25. Reply to Sayed and Meuleman. J Infect Dis. 2017 10 17; 216(7):920-921.
    View in: PubMed
    Score: 0.006
  26. Opposing Effects of Nitazoxanide on Murine and Human Norovirus. J Infect Dis. 2017 09 15; 216(6):780-782.
    View in: PubMed
    Score: 0.006
  27. Genotype-specific acquisition, evolution and adaptation of characteristic mutations in hepatitis E virus. Virulence. 2018 01 01; 9(1):121-132.
    View in: PubMed
    Score: 0.006
  28. PI3K-Akt-mTOR axis sustains rotavirus infection via the 4E-BP1 mediated autophagy pathway and represents an antiviral target. Virulence. 2018 01 01; 9(1):83-98.
    View in: PubMed
    Score: 0.006
  29. RIG-I is a key antiviral interferon-stimulated gene against hepatitis E virus regardless of interferon production. Hepatology. 2017 06; 65(6):1823-1839.
    View in: PubMed
    Score: 0.006
  30. Unphosphorylated ISGF3 drives constitutive expression of interferon-stimulated genes to protect against viral infections. Sci Signal. 2017 Apr 25; 10(476).
    View in: PubMed
    Score: 0.006
  31. Hepatitis E Virus Infects Neurons and Brains. J Infect Dis. 2017 04 15; 215(8):1197-1206.
    View in: PubMed
    Score: 0.006
  32. Direct-acting antiviral therapy for hepatitis E virus? Lancet Gastroenterol Hepatol. 2017 03; 2(3):154-155.
    View in: PubMed
    Score: 0.006
  33. Transcriptional Regulation of Antiviral Interferon-Stimulated Genes. Trends Microbiol. 2017 07; 25(7):573-584.
    View in: PubMed
    Score: 0.006
  34. Biological or pharmacological activation of protein kinase C alpha constrains hepatitis E virus replication. Antiviral Res. 2017 04; 140:1-12.
    View in: PubMed
    Score: 0.006
  35. Distinct Antiviral Potency of Sofosbuvir Against Hepatitis C and E Viruses. Gastroenterology. 2016 12; 151(6):1251-1253.
    View in: PubMed
    Score: 0.006
  36. A Novel Therapeutic Peptide Blocks SARS-CoV-2 Spike Protein Binding with Host Cell ACE2 Receptor. Drugs R D. 2021 Sep; 21(3):273-283.
    View in: PubMed
    Score: 0.002
  37. The impact of COVID-19 pandemic outbreak on education and mental health of Chinese children aged 7-15 years: an online survey. BMC Pediatr. 2021 02 24; 21(1):95.
    View in: PubMed
    Score: 0.002
  38. Unique challenges to control the spread of COVID-19 in the Middle East. J Infect Public Health. 2020 Sep; 13(9):1247-1250.
    View in: PubMed
    Score: 0.002
  39. Chronic hepatitis E in an immunocompetent patient. Clin Res Hepatol Gastroenterol. 2020 06; 44(3):e66-e68.
    View in: PubMed
    Score: 0.002
  40. Interferon regulatory factor 1 eliminates mycobacteria by suppressing p70 S6 kinase via mechanistic target of rapamycin signaling. J Infect. 2019 09; 79(3):262-276.
    View in: PubMed
    Score: 0.002
  41. The Interplay between Host Innate Immunity and Hepatitis E Virus. Viruses. 2019 06 11; 11(6).
    View in: PubMed
    Score: 0.002
  42. The Eukaryotic Translation Initiation Factor 4F Complex Restricts Rotavirus Infection via Regulating the Expression of IRF1 and IRF7. Int J Mol Sci. 2019 Mar 29; 20(7).
    View in: PubMed
    Score: 0.002
  43. Norovirus and rotavirus infections in children less than five years of age hospitalized with acute gastroenteritis in Indonesia. Arch Virol. 2019 Jun; 164(6):1515-1525.
    View in: PubMed
    Score: 0.002
  44. Action and clinical significance of CCAAT/enhancer-binding protein delta in hepatocellular carcinoma. Carcinogenesis. 2019 03 12; 40(1):155-163.
    View in: PubMed
    Score: 0.002
  45. RDW, NLR and RLR in predicting liver failure and prognosis in patients with hepatitis E virus infection. Clin Biochem. 2019 Jan; 63:24-31.
    View in: PubMed
    Score: 0.002
  46. TNF-a exerts potent anti-rotavirus effects via the activation of classical NF-?B pathway. Virus Res. 2018 07 15; 253:28-37.
    View in: PubMed
    Score: 0.002
  47. Hepatitis E virus infection in HIV-infected patients: A large cohort study in Yunnan province, China. J Med Virol. 2018 06; 90(6):1121-1127.
    View in: PubMed
    Score: 0.002
  48. Chronic Hepatitis E in a Renal Transplant Recipient: The First Report of Genotype 4 Hepatitis E Virus Caused Chronic Infection in Organ Recipient. Gastroenterology. 2018 03; 154(4):1199-1201.
    View in: PubMed
    Score: 0.002
  49. Prevalence of human papillomavirus infection in women in the Autonomous Region of Inner Mongolia: A population-based study of a Chinese ethnic minority. J Med Virol. 2018 01; 90(1):148-156.
    View in: PubMed
    Score: 0.001
  50. Prognosis of HIV Patients Receiving Antiretroviral Therapy According to CD4 Counts: A Long-term Follow-up study in Yunnan, China. Sci Rep. 2017 08 29; 7(1):9595.
    View in: PubMed
    Score: 0.001
  51. Genetically Engineered Bacteria for Treating Human Disease. Trends Pharmacol Sci. 2017 09; 38(9):763-764.
    View in: PubMed
    Score: 0.001
  52. Antibodies Against Immune Checkpoint Molecules Restore Functions of Tumor-Infiltrating T Cells in Hepatocellular Carcinomas. Gastroenterology. 2017 10; 153(4):1107-1119.e10.
    View in: PubMed
    Score: 0.001
  53. Nucleoside analogue 2'-C-methylcytidine inhibits hepatitis E virus replication but antagonizes ribavirin. Arch Virol. 2017 Oct; 162(10):2989-2996.
    View in: PubMed
    Score: 0.001
  54. Epigenome-Wide Association Study Identifies Methylation Sites Associated With Liver Enzymes and Hepatic Steatosis. Gastroenterology. 2017 10; 153(4):1096-1106.e2.
    View in: PubMed
    Score: 0.001
  55. Should Nivolumab-Induced Colitis Be Treated by Infliximab? Clin Gastroenterol Hepatol. 2017 10; 15(10):1637.
    View in: PubMed
    Score: 0.001
  56. Factors associated with ethnical disparity in overall survival for patients with hepatocellular carcinoma. Oncotarget. 2017 Feb 28; 8(9):15193-15204.
    View in: PubMed
    Score: 0.001
  57. Action and function of Wnt/ß-catenin signaling in the progression from chronic hepatitis C to hepatocellular carcinoma. J Gastroenterol. 2017 Apr; 52(4):419-431.
    View in: PubMed
    Score: 0.001
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.